martes, 21 de septiembre de 2021

Curarà la CRISPR el VIH??

 


Remember, in 2016, a lung cancer patient became the first person in the world to be treated with a CRISPR therapy: this patient was injected with PD-1 edited T cells in a Chinese clinical trial. This and an American clinical trial using CRISPR-based immunotherapies for cancer have been completed.